Inventor · disambiguated record
Jinzhao Hou
Also filed as: HOU JINZHAO
30 granted patents·47 pending applications·156 citations·filing 1994–2024
96Inventor score
Files withVOYAGER THERAPEUTICS INC65SKYLINE THERAPEUTICS LTD4TULARIK INC3BARNES THOMAS M2ELEVEN BIOTHERAPEUTICS INC1
Top patents by PatentIndex Score
77 records- 0197US11193129B2Modulatory polynucleotidesVOYAGER THERAPEUTICS INC·Filed 2020·Granted Dec 7, 2021·8 cites·20 claims
- 0296US10920227B2Compositions and methods of treating amyotrophic lateral sclerosis (ALS)VOYAGER THERAPEUTICS INC·Filed 2020·Granted Feb 16, 2021·8 cites·22 claims
- 0396US10584337B2Modulatory polynucleotidesVOYAGER THERAPEUTICS INC·Filed 2017·Granted Mar 10, 2020·15 cites·28 claims
- 0495US11198873B2Modulatory polynucleotidesVOYAGER THERAPEUTICS INC·Filed 2020·Granted Dec 14, 2021·7 cites·22 claims
- 0594US11603542B2Compositions and methods of treating amyotrophic lateral sclerosis (ALS)VOYAGER THERAPEUTICS INC·Filed 2018·Granted Mar 14, 2023·7 cites·28 claims
- 0694US11542506B2Compositions and methods of treating amyotrophic lateral sclerosis (ALS)VOYAGER THERAPEUTICS INC·Filed 2021·Granted Jan 3, 2023·3 cites·30 claims
- 0794US10597660B2Compositions and methods of treating amyotrophic lateral sclerosis (ALS)VOYAGER THERAPEUTICS INC·Filed 2015·Granted Mar 24, 2020·11 cites·27 claims
- 0894US10570395B2Modulatory polynucleotidesVOYAGER THERAPEUTICS INC·Filed 2015·Granted Feb 25, 2020·13 cites·22 claims
- 0993US11859200B2AAV capsids with increased tropism to brain tissueVOYAGER THERAPEUTICS INC·Filed 2021·Granted Jan 2, 2024·5 cites·25 claims
- 1092US11434502B2Treatment of amyotrophic lateral sclerosis (ALS)VOYAGER THERAPEUTICS INC·Filed 2018·Granted Sep 6, 2022·5 cites·16 claims
- 1191US10577627B2Chimeric capsidsVOYAGER THERAPEUTICS INC·Filed 2015·Granted Mar 3, 2020·6 cites·28 claims
- 1289US11752181B2Compositions and methods of treating Huntington's diseaseVOYAGER THERAPEUTICS INC·Filed 2018·Granted Sep 12, 2023·4 cites·21 claims
- 1388US2025146000A1Compositions and methods of treating amyotrophic lateral sclerosis (als)VOYAGER THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1487US11512327B2Compositions and methods for delivery of AAVVOYAGER THERAPEUTICS INC·Filed 2018·Granted Nov 29, 2022·3 cites·24 claims
- 1586US2025115917A1Modulatory polynucleotidesVOYAGER THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1684US12123002B2Compositions and methods of treating amyotrophic lateral sclerosis (ALS)VOYAGER THERAPEUTICS INC·Filed 2022·Granted Oct 22, 2024·0 cites·20 claims
- 1781US2025084435A1Treatment of amyotrophic lateral sclerosis (als)VOYAGER THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1878US2024285667A1Central nervous system targeting polynucleotidesVOYAGER THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1977US12116589B2Treatment of amyotrophic lateral sclerosis (ALS)VOYAGER THERAPEUTICS INC·Filed 2022·Granted Oct 15, 2024·0 cites·20 claims
- 2077US12084659B2Modulatory polynucleotidesVOYAGER THERAPEUTICS INC·Filed 2021·Granted Sep 10, 2024·0 cites·24 claims
- 2177US9444441B2Zero-crossing detection circuit and method for synchronous step-down converterSILERGY SEMICONDUCTOR TECHNOLOGY HANGZHOU LTD·Filed 2014·Granted Sep 13, 2016·4 cites·8 claims
- 2277US2024415868A1Compositions and methods for treating huntington's diseaseVOYAGER THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2376US12305189B2Compositions and methods for delivery of AAVVOYAGER THERAPEUTICS INC·Filed 2022·Granted May 20, 2025·0 cites·6 claims
- 2476US12071625B2Modulatory polynucleotidesVOYAGER THERAPEUTICS INC·Filed 2021·Granted Aug 27, 2024·0 cites·23 claims
- 2575US2024226203A9Compositions and methods of treating huntington's diseaseVOYAGER THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2674US12146150B2Rescue of central and peripheral neurological phenotype of friedreich's ataxia by intravenous deliveryVOYAGER THERAPEUTICS INC·Filed 2022·Granted Nov 19, 2024·0 cites·20 claims
- 2774US8853150B2Chimeric IL-1 receptor type I antagonistsBARNES THOMAS M·Filed 2011·Granted Oct 7, 2014·5 cites·115 claims
- 2874US5710266ANucleic acid encoding an interleukin 4 signal transducerTULARIK INC·Filed 1997·Granted Jan 20, 1998·21 cites·3 claims
- 2972US2023399642A1Compositions and methods of treating huntington's diseaseVOYAGER THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3072US2023295663A1Compositions and methods of treating amyotrophic lateral sclerosis (als)VOYAGER THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3168US12467046B2Redirection of tropism of AAV capsidsVOYAGER THERAPEUTICS INC·Filed 2019·Granted Nov 11, 2025·0 cites·29 claims
- 3268US5618693AInterleukin-2 signal transducers and binding assaysTULARIK INC·Filed 1995·Granted Apr 8, 1997·20 cites·28 claims
- 3367US12180500B2Chimeric capsidsVOYAGER THERAPEUTICS INC·Filed 2020·Granted Dec 31, 2024·0 cites·10 claims
- 3466US2025388626A1Aav capsid variants and uses thereofVOYAGER THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3566US2025215453A1Aav capsid variants and uses thereofVOYAGER THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3665US11951121B2Compositions and methods for treating Huntington's diseaseVOYAGER THERAPEUTICS INC·Filed 2017·Granted Apr 9, 2024·0 cites·29 claims
- 3765US2023203102A1Redirection of tropism of aav capsidsVOYAGER THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3865US2019365793A1Central nervous system targeting polynucleotidesVOYAGER THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3964US2022333131A1Modulatory polynucleotidesVOYAGER THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4063US2025243263A1Tau binding compoundsVOYAGER THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4160US12281321B2Frataxin expression constructs having engineered promoters and methods of use thereofVOYAGER THERAPEUTICS INC·Filed 2019·Granted Apr 22, 2025·0 cites·42 claims
- 4260US2025034559A1Compositions and methods for the treatment of tau-related disordersVOYAGER THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4360US2022096657A1Compositions for the treatment of diseaseVOYAGER THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4459US2025049955A1Compositons and methods for the treatment of neurological disorders related to glucosylceramidase beta deficiencyVOYAGER THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4558US12485188B2Recombinant adeno-associated virus with modified AAV capsid polypeptidesSKYLINE THERAPEUTICS LTD·Filed 2024·Granted Dec 2, 2025·0 cites·20 claims
- 4658US2025066812A1Recombinant aav for the gene therapy of fabry diseaseSKYLINE THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 4758US2025223376A1Compositions and methods for the treatment of her2 positive cancerVOYAGER THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4858US2025011372A1Aav capsid variants and uses thereofVOYAGER THRAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4957US2023285596A1Compositions and methods for the treatment of niemann-pick type c1 diseaseVOYAGER THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 5056US9458216B2Nucleic acid encoding chimeric IL-1 receptor type I antagonistsELEVEN BIOTHERAPEUTICS INC·Filed 2014·Granted Oct 4, 2016·0 cites·29 claims
Showing the top 50 of 77 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jinzhao Hou files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →